Tacrolimus Ointment 01 + Erythromycin Interaction
Moderateinteraction on record
Description
CYP3A4 inhibitor; concomitant use in patients with widespread and/or erythrodermic disease should be done with caution due to potential increased tacrolimus absorption.
Mechanism
CYP3A4 inhibition
Source: NLP:tacrolimus ointment 0.1%